{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:50:05Z","timestamp":1778615405476,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jiac.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T21:15:35Z","timestamp":1492809335000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of interferon-\u03b3 release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation"],"prefix":"10.1016","volume":"23","author":[{"given":"Satoru","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Igari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotake","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Tsuyuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Saigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.04.002_bib1","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.04.002_bib3","series-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jiac.2017.04.002_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","article-title":"Screening for tuberculosis infection prior to initiation of anti-TNF therapy","volume":"8","author":"Lalvani","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jiac.2017.04.002_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200608-1099OC","article-title":"Comparison of two interferon-\u03b3 assays and tuberculin skin test for tracing tuberculosis contacts","volume":"175","author":"Arend","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. LTBI in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib9","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jiac.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s15010-012-0291-0","article-title":"Comparison of the tuberculin skin test and interferon-\u03b3 release assay for the diagnosis of latent tuberculosis infection before kidney transplantation","volume":"41","author":"Kim","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","article-title":"Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country","volume":"22","author":"Stephan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-\u03b3 assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.5588\/ijtld.12.0004","article-title":"Combined use of a TST and the T-SPOT.TB assay for latent tuberculosis infection diagnosis before anti-TNF-\u03b1 treatment","volume":"16","author":"Jung","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.05058-11","article-title":"Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers","volume":"18","author":"Ringshausen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jiac.2017.04.002_bib16","first-page":"415","article-title":"Current epidemiological trend of tuberculosis in Japan","volume":"6","author":"Ohmori","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib17","first-page":"1021","article-title":"Waning of the specific interferon-gamma response after years of tuberculosis infection","volume":"11","author":"Mori","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.002_bib20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.04.002_bib21","unstructured":"http:\/\/www.jata.or.jp\/rit\/ekigaku\/index.php\/download_file\/-\/view\/961\/ [Accessed on 17 February 2017]."},{"key":"10.1016\/j.jiac.2017.04.002_bib22","first-page":"365","article-title":"Estimation of positive rates of interferon gamma release assay by age group","volume":"92","author":"Kato","year":"2017","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2017.04.002_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-\u03b3) release Assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:16Z","timestamp":1761159376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1341321X17300879"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of interferon-\u03b3 release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}